Biotechnology Innovation Organization· @IAmBiotech · X·· 16 天前精选AI 评分62
AI 导读
BIO 生物技术创新组织表示，药品关税豁免的不确定性已在全行业影响投资与研发决策，距离实施仅剩两周，联邦层面仍未发布指导意见。该组织附上了相关报道链接，讨论关税临近而合规指引仍缺失的问题。
推荐理由
关税豁免细则未明，行业投资与研发决策已受影响，可了解政策落地前的合规不确定性。
正文
Uncertainty over pharmaceutical tariff exemptions is already complicating investment and R&D decisions industry-wide - with implementation two weeks away and no federal guidance yet issued. Read the full story: https://bio.news/latest-news/with-pharmaceutical-tariffs-looming-guidance-on-compliance-is-still-lacking/
来源：Biotechnology Innovation Organization · x.com